Novelix Pharmaceuticals Hits Upper Circuit on Technology Transfer Deal with Germany’s GMBU e.V.
Hyderabad, October 17 (Udaipur Kiran): Shares of Novelix Pharmaceuticals surged nearly 5% on Friday, hitting the upper circuit limit of ₹44.15, after the company announced signing a Technology Transfer Agreement with Germany-based GMBU e.V. to advance large-scale production of Astaxanthin, a powerful antioxidant used in nutraceutical and pharmaceutical applications. The stock opened at ₹44.15 and … Read more

